Astellas Pharma Inc. et al v. Aurobindo Pharma Ltd. et al
| Astellas Pharma Global Development, Inc., Astellas Pharma Inc. and Astellas Ireland Co., Ltd. |
| Teva Pharmaceuticals USA, Inc., Cadila Healthcare Ltd. doing business as Zydus Cadila, Actavis LLC, Lupin Ltd., Lupin Pharmaceuticals, Inc., Actavis Elizabeth LLC, Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd., Zydus Pharmaceuticals (USA) Inc. and Aurolife Pharma LLC |
| 1:2021cv00425 |
| March 24, 2021 |
| US District Court for the District of Delaware |
| Joseph F Bataillon |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 2, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 7 MOTION for Pro Hac Vice Appearance of Attorney Simon D. Roberts and Jason A. Leonard - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: #1 Certification of S. Roberts, #2 Certification of J. Leonard)(Silver, Daniel) |
| Case Assigned to Judge Joseph F. Bataillon of the U.S. District Court for the District of Nebraska, due to related cases. Please include the initials of the Judge (JFB) after the case number on all documents filed. (rjb) |
| Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (kmd) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas B.V. for Astellas Ireland Co., Ltd.; Corporate Parent Astellas US Holding, Inc. for Astellas Pharma Global Development, Inc. - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. (kmd) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,842,780. (kmd) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/9/2021, 3/16/2021, 3/3/2021, 2/8/2021. Date of Expiration of Patent: 9/28/2029.Thirty Month Stay Deadline: See Attached. (kmd) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) |
| Filing 1 COMPLAINT for Patent Infringement filed against Actavis Elizabeth LLC, Actavis LLC, Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Aurolife Pharma LLC, Cadila Healthcare Ltd., Lupin Ltd., Lupin Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc., Zydus Pharmaceuticals (USA) Inc. - Magistrate Consent Notice to Pltf. (Filing fee $402, receipt number ADEDC-3578624.) - filed by Astellas Pharma Global Development, Inc., Astellas Ireland Co., Ltd., Astellas Pharma Inc. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(kmd) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
